HANOI, May 27 (Reuters) - French pharmaceutical company Sanofi (SASY.PA), opens new tab said on Tuesday it was exploring opportunities for producing vaccines in Vietnam in cooperation with local ...

From Sanofi’s perspective, the collaboration “aims to explore opportunities for local vaccine production in Vietnam as part of our ongoing commitment to improving vaccine access in the country ...

French pharmaceutical major Sanofi SA (SNY) on Tuesday reportedly launched a vaccine manufacturing facility in Vietnam with Vietnam Vaccine JSC (VNVC). Following the news, Nasdaq-listed shares of ...

In Vietnam, Sanofi provides tens of millions of high-quality vaccine doses, including Hexaxim (6-in-1), Tetraxim (4-in-1), Adacel (3-in-1), Verorab rabies vaccine, Menactra meningococcal vaccine, and ...

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. Vietnam Vaccine JSC ...

Investing.com -- Sanofi (NASDAQ: SNY), in collaboration with Vietnam Vaccine JSC (VNVC), launched a vaccine production facility in Vietnam on Tuesday. The manufacturing plant is designed to ...

Nature Biotechnology - Sanofi's dengue vaccine first to complete phase 3. ... Malaysia, the Philippines, Thailand and Vietnam, protection was 56% compared with placebo.

French pharmaceutical company Sanofi said on Tuesday it was exploring opportunities for producing vaccines in Vietnam in cooperation with local partner Vietnam Vaccine Company (VNVC), which announced ...

HANOI ― Sanofi and Vietnam Vaccine JSC, or VNVC, on Tuesday launched a vaccine manufacturing facility in Vietnam, aimed at producing vaccines for domestic use and export. The launch was ...

The launch was witnessed by French President Emmanuel Macron during his visit to the Southeast Asian country. The plant, situated in the southern province of Long An, spans 2.6 hectares (6.4 acres) ...